Lv41
660 积分 2024-12-22 加入
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study
10天前
已完结
Risk factors of dapagliflozin-associated diabetic ketosis/ketoacidosis in patients with type 2 diabetes mellitus: A matched case-control study
10天前
已完结
Risk of Euglycemic Diabetic Ketoacidosis in Patients Taking Sodium Glucose Transporter 2 Inhibitors Undergoing Endoscopies
11天前
已完结
The risk factors of diabetic ketosis and diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a retrospective study
27天前
已完结
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
2个月前
已完结
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
2个月前
已完结
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
2个月前
已完结
Effect of sodium-glucose cotransporter-2 inhibitors on kidney outcomes of individuals with type 2 diabetes according to blood pressure levels
3个月前
已完结
Sex Differences in the Association Between Thyroid Hormone Sensitivity and Cardiovascular-Kidney-Metabolic Syndrome
4个月前
已完结
Cardiovascular-kidney-metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD
4个月前
已关闭
皖公网安备34019202002308
